Welcome to the MDS Patient Message Board Post New Thread

Welcome to the MDS Patient Message Board. We hope that you will find this to be a very valuable resource in your journey. We have recently revised the format of our forum to be much more user friendly and pleasing on the eyes. Let us know if you have any problems, or if you have additional suggestions on how we might further improve our site.

Geron

This topic has 2 replies, 3 voices, and was last updated 5 months, 1 week ago by Jimmy Greenhut.

Viewing 3 posts - 1 through 3 (of 3 total)

Author

Posts
March 3, 2023 at 9:14 am #59325

Joe Catalano
Participant

Has anyone heard ANYTHING? About this?
Imetelstat Provides Durable Transfusion Independence in Lower-Risk MDS
Jan 4, 2023
By Kristi Rosa

Significant and durable transfusion independence was achieved with imetelstat vs placebo in patients with lower-risk myelodysplastic syndromes who were relapsed, refractory, or ineligible for erythropoiesis-stimulating agents, meeting the primary and a key secondary end point of the phase 3 IMerge trial.

March 18, 2023 at 9:00 am #59332

Anonymous
Inactive

Hi Joe, Here is a recent press release on Imetelstat:
Geron Announces Positive Top-Line Results from IMerge Phase 3 Trial of Imetelstat in Lower Risk MDS

https://ir.geron.com/investors/press-releases/press-release-details/2023/Geron-Announces-Positive-Top-Line-Results-from-IMerge-Phase-3-Trial-of-Imetelstat-in-Lower-Risk-MDS/default.aspx

April 14, 2023 at 11:26 am #61763

Jimmy Greenhut
Participant

Hi Joe, I’ve been in treatment with the phase 3 trial @ Moffit. Going for my 13th treatment end of the month. Imetelstat did manage to get me from 7 pints a month to almost 8 week transfusion independence. My 11th & 12th treatments I had allergic reaction instantly. It never raised my HGB to bloodlet. Feb 3 pints, March 2 pints. Fatigued, weakness are major issues & gastro. Will see how long I’ll be in the study? FDA is going to approve it in 2024
Author

Posts